Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial
- Lu Chen
- Shujie Zhai
- Yayue Liu
- Wenchen Gong
- Feng Fang
- Qiang Wu
- Yunlong Cui
- Wei Zhang
- Huikai Li
- Yongmei Li
- Jihui Hao
- Tianqiang Song
2026-01-08